IN2014DN06911A - - Google Patents
Info
- Publication number
- IN2014DN06911A IN2014DN06911A IN6911DEN2014A IN2014DN06911A IN 2014DN06911 A IN2014DN06911 A IN 2014DN06911A IN 6911DEN2014 A IN6911DEN2014 A IN 6911DEN2014A IN 2014DN06911 A IN2014DN06911 A IN 2014DN06911A
- Authority
- IN
- India
- Prior art keywords
- dioleylphosphatidylcholine
- tocopherol
- falls
- range
- blend concentration
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases, cochleates; Sponge phases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A61K9/0051—Ocular inserts, ocular implants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Ophthalmology & Optometry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Dermatology (AREA)
- Neurosurgery (AREA)
- Dispersion Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2012018062 | 2012-01-31 | ||
PCT/JP2013/051951 WO2013115201A1 (ja) | 2012-01-31 | 2013-01-30 | 非水性液体組成物 |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2014DN06911A true IN2014DN06911A (pt) | 2015-05-15 |
Family
ID=48905235
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN6911DEN2014 IN2014DN06911A (pt) | 2012-01-31 | 2013-01-30 |
Country Status (12)
Country | Link |
---|---|
US (1) | US20150011518A1 (pt) |
EP (1) | EP2810657B1 (pt) |
JP (1) | JP2013177372A (pt) |
KR (1) | KR20150000874A (pt) |
CN (1) | CN104080478A (pt) |
CA (1) | CA2861261A1 (pt) |
EA (1) | EA201491453A1 (pt) |
IN (1) | IN2014DN06911A (pt) |
PH (1) | PH12014501689A1 (pt) |
SG (2) | SG11201404230QA (pt) |
TW (1) | TW201336526A (pt) |
WO (1) | WO2013115201A1 (pt) |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9514878D0 (en) * | 1995-07-20 | 1995-09-20 | Danbiosyst Uk | Vitamin E as a solubilizer for drugs contained in lipid vehicles |
CA2286052A1 (en) * | 1997-04-17 | 1998-10-29 | Lise Sylvest Nielsen | A novel bioadhesive drug delivery system based on liquid crystals |
US7731947B2 (en) * | 2003-11-17 | 2010-06-08 | Intarcia Therapeutics, Inc. | Composition and dosage form comprising an interferon particle formulation and suspending vehicle |
JP4496406B2 (ja) | 2003-03-07 | 2010-07-07 | 参天製薬株式会社 | 4−ピリジルアルキルチオ基を置換基として有する新規化合物 |
CN1897918A (zh) * | 2003-11-17 | 2007-01-17 | 阿尔萨公司 | 包含两亲性分子作为混悬载体的组合物和剂型 |
JP4626353B2 (ja) | 2004-02-17 | 2011-02-09 | 参天製薬株式会社 | 置換又は無置換アミノ基を導入した4−ピリジルアルキルチオ基を有する新規環式化合物 |
GB0412530D0 (en) * | 2004-06-04 | 2004-07-07 | Camurus Ab | Formulation |
ES2309766T3 (es) * | 2004-06-04 | 2008-12-16 | Camurus Ab | Formulaciones liquidas de liberacion lenta. |
PL1848403T3 (pl) * | 2005-01-14 | 2010-09-30 | Camurus Ab | Preparaty bioadhezyjne o działaniu miejscowym |
PL1843746T3 (pl) * | 2005-01-14 | 2011-09-30 | Camurus Ab | Formulacje analogów somatostatyny |
EP1843751B1 (en) * | 2005-01-21 | 2020-09-30 | Camurus Ab | Pharmaceutical lipid compositions |
JP4585978B2 (ja) | 2005-03-03 | 2010-11-24 | 参天製薬株式会社 | キノリルアルキルチオ基を有する新規環式化合物 |
JP4834441B2 (ja) | 2005-03-31 | 2011-12-14 | 参天製薬株式会社 | ピリミジニルアルキルチオ基を有する新規環式化合物 |
JP5198261B2 (ja) * | 2005-06-06 | 2013-05-15 | カムルス エービー | Glp−1類似体製剤 |
JP4825636B2 (ja) | 2005-09-14 | 2011-11-30 | 参天製薬株式会社 | グルココルチコイド受容体結合活性を有する新規1,2−ジヒドロキノリン誘導体 |
JP5054996B2 (ja) | 2006-03-14 | 2012-10-24 | 参天製薬株式会社 | グルココルチコイド受容体結合活性を有する新規1,2,3,4−テトラヒドロキノキサリン誘導体 |
PL2085387T3 (pl) | 2006-11-14 | 2013-09-30 | Ayumi Pharmaceutical Corp | Nowe pochodne 1,2-dihydrochinoliny zawierające jako podstawniki fenylochalkogeno-podstawioną niższą grupę alkilową oraz wprowadzoną przez ester grupę fenylową |
CN103224493A (zh) | 2007-01-29 | 2013-07-31 | 参天制药株式会社 | 具有血管新生抑制活性的新型噁二唑衍生物及噻二唑衍生物 |
PL2151436T3 (pl) | 2007-05-29 | 2013-09-30 | Santen Pharmaceutical Co Ltd | Nowe pochodne 1,2,3,4-tetrahydrochinoksaliny, które jako podstawnik zawierają grupę fenylową z wprowadzoną strukturą estru kwasu sulfonowego lub amidu kwasu sulfonowego i które mają aktywność wiążącą wobec receptora glukokortykoidowego |
WO2009035068A1 (ja) | 2007-09-13 | 2009-03-19 | Santen Pharmaceutical Co., Ltd. | 新規1,3,3-トリメチル-7-フェニル-3,4-ジヒドロ-1h-キノキサリン-2-オン誘導体 |
CA2767992C (en) | 2009-07-17 | 2017-03-21 | Santen Pharmaceutical Co., Ltd. | 2 - [[[2 -[(hydroxyacetyl) amino]- 4 -pyridinyl] methyl] thio]- n -[4 - (trifluoromethoxy) phenyl]- 3 -pyridinecarboxamide benzenesulfonate, crystal of same, crystal polymorph thereof, and methods for production thereof |
US8956600B2 (en) * | 2009-08-10 | 2015-02-17 | Taiwan Liposome Co. Ltd. | Ophthalmic drug delivery system containing phospholipid and cholesterol |
-
2013
- 2013-01-30 SG SG11201404230QA patent/SG11201404230QA/en unknown
- 2013-01-30 SG SG10201606271RA patent/SG10201606271RA/en unknown
- 2013-01-30 US US14/375,251 patent/US20150011518A1/en not_active Abandoned
- 2013-01-30 WO PCT/JP2013/051951 patent/WO2013115201A1/ja active Application Filing
- 2013-01-30 KR KR20147023427A patent/KR20150000874A/ko not_active Application Discontinuation
- 2013-01-30 JP JP2013015164A patent/JP2013177372A/ja active Pending
- 2013-01-30 CN CN201380007257.3A patent/CN104080478A/zh active Pending
- 2013-01-30 CA CA 2861261 patent/CA2861261A1/en not_active Abandoned
- 2013-01-30 IN IN6911DEN2014 patent/IN2014DN06911A/en unknown
- 2013-01-30 EA EA201491453A patent/EA201491453A1/ru unknown
- 2013-01-30 EP EP13744346.1A patent/EP2810657B1/en not_active Not-in-force
- 2013-01-30 TW TW102103410A patent/TW201336526A/zh unknown
-
2014
- 2014-07-25 PH PH12014501689A patent/PH12014501689A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
JP2013177372A (ja) | 2013-09-09 |
WO2013115201A1 (ja) | 2013-08-08 |
TW201336526A (zh) | 2013-09-16 |
EP2810657A4 (en) | 2015-07-29 |
SG10201606271RA (en) | 2016-09-29 |
EA201491453A1 (ru) | 2014-12-30 |
SG11201404230QA (en) | 2014-10-30 |
US20150011518A1 (en) | 2015-01-08 |
PH12014501689A1 (en) | 2014-10-20 |
CA2861261A1 (en) | 2013-08-08 |
EP2810657A1 (en) | 2014-12-10 |
EP2810657B1 (en) | 2016-09-21 |
CN104080478A (zh) | 2014-10-01 |
KR20150000874A (ko) | 2015-01-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU348190S (en) | Hitch ball mount | |
PH12015500115A1 (en) | Glucagon analogues | |
CL2014002564A1 (es) | Composiciones para tratamiento de agua que comprende un coagulante que contiene aluminio y un polisacarido no derivado natural, en donde la relacion entre el polisacarido y el coagulante es entre 1:10 hasta 1:100; y métodos de uso. | |
MY170623A (en) | Additive for preparing suede on monocrystalline silicon chip and use method thereof | |
MX370903B (es) | Composiciones de ácido percarboxílico estables y sus usos. | |
CL2015003738A1 (es) | Formulación líquida estable de amg-416 (velcalcetida) | |
EP3083925A4 (en) | Stable liquid compositions containing enzymes and peroxides | |
CA2862669A1 (en) | Application of fluorescent dyes to trace and quantify chemical dosage in industrial wastewater | |
IN2014MN01553A (pt) | ||
ZA201504341B (en) | Biodegradable additive concentrate improving the lubricity of aqueous sludges, use thereof and aqueous sludge for drilling | |
AU352917S (en) | Trailer jack | |
MX2013008277A (es) | Composicion liquida y acousa de bromfenaco, que tiene efectividad conservadora. | |
IN2014DN06911A (pt) | ||
PH12014501307A1 (en) | Liquid activation system | |
AR097717A1 (es) | Composición gelatinizable con alto contenido de sal para el tratamiento de pozos | |
CL2015001397A1 (es) | Compuestos derivados de 4-amino-7,8-dihidropirimido[5,4-f][1,4]oxazepin-5(6h)-ona, inhibidores de diacilglicerol aciltransferasa; composicion farmaceutica y el uso en el tratamiento de la obesidad. | |
GR1008101B (el) | Ποσιμα διαλυματα φυλλικου οξεος | |
BR112015007885A2 (pt) | composição nutritiva inorgânica de ferro | |
WO2011092655A3 (en) | Mentha suaveolens essential oil and therapeutic activities thereof | |
MX2015004318A (es) | Metodos para prevenir la emulsificacion de petroleo crudo en fluidos de tratamiento de pozos. | |
FENG | The Personalized Society and the Mao Yushi Phenomenon | |
AU352959S (en) | Trailer jack | |
AU201215085S (en) | Floatation device | |
AU352595S (en) | Label for hitch match system | |
AU345696S (en) | Textiles |